Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 83%
In fiscal 2025, Jaguar Health, Inc. reported revenue of $12M, down 1.5% year over year. Operating margin was -398.8% and net margin -465.4%, on a free-cash-flow margin of n/a with capital expenditure at n/a of revenue. Every figure is computed directly from JAGX's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $12M | -398.8% | -465.4% |
| FY2024 | $12M | -263.8% | -329.3% |
| FY2023 | $10M | -351.3% | -0.4% |
| FY2022 | $12M | -287.8% | -0.4% |
| FY2021 | $4M | -939.1% | -1.2% |
How does JAGX compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.